Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)

 

Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
back to doctor search

Neurology

Anahita Deboo, MD

Anahita Deboo
Schedule appointment

Telemedicine appointments may be available for this physician.

Learn more about virtual visits

Specialties

Neurology

4.8
83 Patient Satisfaction Ratings
about me
offices
publications
ratings & reviews
about me
offices

Office Locations

Temple Neurology

Temple University Hospital – Main Campus

3401 N. Broad Street

Ambulatory Care Center, Suite D-101

Philadelphia, PA 19140

800-TEMPLE-MED

publications
Selected Publications

Deboo A. Numbness and Paresthesias in the Elderly. Geriatrics and Aging 2003; 6:11-15.

Gordon P, Moore D, Miller R, Florence J, et al for the Western ALS Study Group. Efficacy of Minocycline in Patients with Amyotrophic Lateral Sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6(12):1045-1053.

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial. Kaufmann P, Levy G, Montes J, et al for the QALS study group. Amyotrophic Lateral Sclerosis; 2007:8(1):42-46.

Kaufmann P, Thompson J, Levy G, et al and the QALS Study Group. Phase II Trial of CoQ10 in ALS Finds Insufficient Evidence to Justify Phase III. Ann Neurol. 2009;66(2):235-44.

Buchsbaum R, Kaufmann P, Barsdorf AI, and the QALS Study Group. Web-based data management for a phase II clinical trial in ALS. Amyotroph Lateral Scler. 2009:10(5-6):374-7.

Aggarwal S, Zinman L, Simpson E, McKinley J, et al. Safety and Efficacy of Lithium in Combination with Riluzole for Treatment of Amyotrophic Lateral Sclerosis: a Randomised, Double-blind, Placebo-controlled Trial. Lancet Neurol. 2010;9(5):481-8.

Sanders DB, Rosenfeld J, Dimachkie MM, Meng L, Malik F for the Tirasemtiv in Myasthenia Gravis Study Group. A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis. Neurotherapeutics. 2015 Apr;12(2):455-60.

Dey S, Roshal D, Rojas L, Schwartzman R, Deboo A, Heiman-Patterson T. Intravenous Lidocaine as a Treatment for Refractory Myotonia Congenita. Drexel Med Journal. 2016: 10(1): 54-58.

Deboo A, Heiman-Patterson TD. Amyotrophic lateral sclerosis. In: Textbook of Internal Medicine - An Intensive Board Review with 1000 MCQs. Baliga RR (ed). Blendon-Miller 2015 (in press).

Heiman-Patterson TD, Pillai A, Deboo A, Sherman M. Standard equations are Poor Predictors of Caloric Expenditure in Patients with Amyotrophic Lateral Sclerosis. 55th Annual Meeting of the American Academy of Neurology; 2003:P01.158.

Hyman BA, Sherman M, Deboo A, Mitchell M, Carlson D, Heiman-Patterson T. Positional Changes in Forced Vital Capacity in Bulbar vs Non-Bulbar ALS Patients. 15th International Symposium on ALS/MND; 2004: P118.

Heiman-Patterson T, Deboo A, Saadiq R, Sebestian J, Joseph K, Sherman M. Substrate Utilization in Hypermetabolic Amyotrophic Lateral Sclerosis (ALS) Patients. 59th Annual Meeting of the American Academy of Neurology; 2007:P01.088.

Russo G, Chen J, Saadiq R, Barr C, Deboo A, Heiman-Patterson T. Non-invasive Measurement of Mouth to Colon Transit Time in Patients with Amyotrophic Lateral Sclerosis (ALS). 19th International Symposium on ALS/MND; 2008:P170.

King J, Feldman S, Heiman-Patterson T, Deboo A, Vaughan T, Sellers E, Wolpaw J. An EEG Impedance Correlation Study for Brain Computer Interface. 19th International Symposium on ALS/MND; 2008:P215.

Nieves C, Eppig J, Libon D, Harris D, Feldman S, Paolone M, Rojas L, Deboo A, Heiman-Patterson T. Forced Vital Capacity, Bulbar Onset, and Neuropsychological Impairment in Amyotrophic lateral sclerosis (ALS). Neurology 2012; 78(suppl 1):P04.231.

Harris D, Eppig J, Nieves C, Paolone M, Deboo A, Heiman-Patterson T. Forced Vital Capacity, Neuropsychological Impairment, and Amyotrophic Lateral Sclerosis. 23rd International Symposium on ALS/MND; 2012:P210.

Amerstein M, Deboo A, Heiman-Patterson T, Harris D. Barriers to PEG Tube Placement in Patients with ALS and the Effect of Video-Based Education on Their Perceptions and Choices. 23rd International Symposium on ALS/MND; 2012:CW301.

Heiman-Patterson T, Wicas G, Eppig, J, Nieves C, Harris D, Paolone M, Deboo A, Libon D. Comparison of Cognitive Changes in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis using the Philadelphia Brief Assessment of Cognition (PBAC) Testing Paradigm. Northeast ALS Consortium (NEALS) Meeting 2012.

Scull L, Ayaz H, Shewokis P, Libon D, Wicas G, Eppig J, Feldman S, Deboo A, Heiman-Patterson T. Use of FNIR to Examine Hemodynamic Changes During Cognitive Tasks in Individuals with ALS. 24th International Symposium on ALS/MND; 2013:P63.

Libon D, Heiman-Patterson T, Lippa C, Wicas G, Eppig J, Scull L, Deboo A. Cross-Sectional and Longitudinal Neuropsychological Assessment in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis. Neurology 2013;80(meeting abstracts):P07.166.

Fayyaz T, Edwards J, Scull L, Ayaz H, Shewokis P, Libon D, Deboo A, Heiman-Patterson, T. Cortical Hemodynamics Assessment in ALS During Cognitive Testing Using Functional Near Infrared Spectroscopy (fNIR). 66th Annual Meeting of the American Academy of Neurology; 2014:P4.100

Dey S, Roshal D, Rojas L, Schwartzman R, Deboo A, Heiman-Patterson T. Assessment of 2 Patients with Myotonia Congenita Following Intravenous Lidocaine Treatment. 66th Annual Meeting of the American Academy of Neurology; 2014:P7.095.

Edwards J, Fayyaz T, Scull L, Ayaz H, Shewokis P, Libon D, Lippa C, Deboo A, Heiman-Patterson, T. Functional Near-Infrared Spectroscopy (fNIR) based Detection of increased Prefrontal Cortex Activity in Frontotemporal Dementia. 66th Annual Meeting of the American Academy of Neurology; 2014:P3.217.

Heiman-Patterson T, Dey S, Alexander G, Deboo A. Application of a Staging System to the ProAct Database Population. 25th International Symposium on ALS/MND; 20014:P143.

ratings & reviews

83 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about Patient Satisfaction Rating.

OVERALL RATING

4.80 / 5.0

RATINGS BREAKDOWN

4.7
Give easy to understand instruction
4.8
Provider expl in way you understand
4.9
Provider listen carefully to you
4.9
Show respect for what you say
4.8
Spend enough time with you
PATIENT COMMENTS
5.0
June 29, 2021

Dr. Deboo is always exceptional in all ways. She is the best.

5.0
June 25, 2021

Dr. Deboo is smart, caring and patient.

5.0
March 1, 2021

I have always had a good relationship with Dr. DeBoo. She is very competent and very knowledgeable about my health issue. I fully trust her as my health provider.

5.0
December 26, 2020

very courteous.. good experience

5.0
December 2, 2020

I trust and love Dr. Deboo.

4.0
November 25, 2020

Dr. Deboo was great. [...]

5.0
November 14, 2020

Everyone on Dr. DeBoo's staff are very kind and compassionate.

5.0
September 28, 2020

excellent experience

5.0
August 18, 2020

Dr. Deboo is a excellent, caring & knowledgeable doctor. We are delighted with her care & that of the staff.

5.0
August 14, 2020

Dr. Deboo has called me several times at my home. I am very thankful for her and her staff for their care and concern for me.

5.0
June 30, 2020

Very good.